CCDC85C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.849200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.188200E-01
Normal-vs-Stage2
2.787400E-01
Normal-vs-Stage3
7.183600E-01
Normal-vs-Stage4
8.479200E-01
Stage1-vs-Stage2
3.263800E-01
Stage1-vs-Stage3
2.436600E-01
Stage1-vs-Stage4
2.519600E-01
Stage2-vs-Stage3
3.735600E-01
Stage2-vs-Stage4
3.227000E-01
Stage3-vs-Stage4
9.311800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.663000E-01
Normal-vs-AfricanAmerican
4.312600E-01
Normal-vs-Asian
5.195000E-01
Caucasian-vs-AfricanAmerican
5.216000E-01
Caucasian-vs-Asian
2.780000E-01
AfricanAmerican-vs-Asian
8.523000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.797800E-01
Normal-vs-Female
2.937800E-01
Male-vs-Female
8.626600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.599430E-01
Normal-vs-Age(41-60Yrs)
1.792780E-01
Normal-vs-Age(61-80Yrs)
3.652600E-01
Normal-vs-Age(81-100Yrs)
3.615600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.486550E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.381600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.678600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.679600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.497200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.020800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.871800E-01
Normal-vs-Daily Drinker
3.465200E-01
Normal-vs-Weekly Drinker
3.696800E-01
Normal-vs-Occasional Drinker
1.184950E-01
Normal-vs-Social Drinker
9.357800E-02
Non Drinker-vs-Daily Drinker
4.873400E-01
Non Drinker-vs-Weekly Drinker
9.460800E-01
Non Drinker-vs-Occasional Drinker
4.105000E-01
Non Drinker-vs-Social Drinker
1.255990E-01
Daily Drinker-vs-Weekly Drinker
5.848200E-01
Daily Drinker-vs-Occasional Drinker
9.702400E-01
Daily Drinker-vs-Social Drinker
4.322200E-01
Weekly Drinker-vs-Occasional Drinker
4.808400E-01
Weekly Drinker-vs-Social Drinker
1.419380E-01
Occasional Drinker-vs-Social Drinker
2.805000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.731020E-01
Normal-vs-Grade 2
9.277600E-02
Normal-vs-Grade 3
3.419700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.519600E-01
Grade 1-vs-Grade 3
8.438200E-01
Grade 1-vs-Grade 4
1.731020E-01
Grade 2-vs-Grade 3
1.298240E-01
Grade 2-vs-Grade 4
9.277600E-02
Grade 3-vs-Grade 4
3.419700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.361600E-01
Normal-vs-NonDiabetic
2.262600E-01
Diabetic-vs-NonDiabetic
4.812000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.449400E-01
Normal-vs-NoPancreatitis
2.965200E-01
Pancreatitis-vs-NoPancreatitis
4.715200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.391200E-01
Normal-vs-N1
2.852800E-01
N0-vs-N1
4.440800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.006780E-01
Normal-vs-TP53-NonMutant
2.716400E-01
TP53-Mutant-vs-TP53-NonMutant
1.244150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
